Biofil Chemicals and Pharmaceuticals Limited (BIOFILCHEM.BO)

INR 42.72

(0.73%)

Total Assets Summary of Biofil Chemicals and Pharmaceuticals Limited

  • Biofil Chemicals and Pharmaceuticals Limited's latest annual total assets in 2023 was 470.82 Million INR , up 49.92% from previous year.
  • Biofil Chemicals and Pharmaceuticals Limited's latest quarterly total assets in 2023 FY was 470.82 Million INR , up 49.92% from previous quarter.
  • Biofil Chemicals and Pharmaceuticals Limited reported annual total assets of 314.05 Million INR in 2022, up 67.66% from previous year.
  • Biofil Chemicals and Pharmaceuticals Limited reported annual total assets of 187.32 Million INR in 2021, down -43.64% from previous year.
  • Biofil Chemicals and Pharmaceuticals Limited reported quarterly total assets of 422.16 Million INR for 2023 Q2, down 0.0% from previous quarter.
  • Biofil Chemicals and Pharmaceuticals Limited reported quarterly total assets of 470.82 Million INR for 2023 FY, up 49.92% from previous quarter.

Annual Total Assets Chart of Biofil Chemicals and Pharmaceuticals Limited (2023 - 2008)

Historical Annual Total Assets of Biofil Chemicals and Pharmaceuticals Limited (2023 - 2008)

Year Total Assets Total Assets Growth
2023 470.82 Million INR 49.92%
2022 314.05 Million INR 67.66%
2021 187.32 Million INR -43.64%
2020 332.38 Million INR -21.54%
2019 423.64 Million INR 74.97%
2018 242.13 Million INR 0.24%
2017 241.54 Million INR 10.6%
2016 218.4 Million INR -9.5%
2015 241.31 Million INR 75.42%
2014 137.56 Million INR -5.77%
2013 145.98 Million INR 8.19%
2012 134.93 Million INR -4.36%
2011 141.08 Million INR 35.91%
2010 103.81 Million INR 1.26%
2009 102.52 Million INR 22.09%
2008 83.97 Million INR 0.0%

Peer Total Assets Comparison of Biofil Chemicals and Pharmaceuticals Limited

Name Total Assets Total Assets Difference
Alembic Pharmaceuticals Limited 64.45 Billion INR 99.27%
Aurobindo Pharma Limited 450.71 Billion INR 99.896%
Glenmark Life Sciences Limited 28.5 Billion INR 98.348%
Granules India Limited 55.2 Billion INR 99.147%
Indoco Remedies Limited 21.44 Billion INR 97.805%
Achyut Healthcare Limited 309.52 Million INR -52.114%
Ajanta Pharma Limited 46.38 Billion INR 98.985%
Alkem Laboratories Limited 155.74 Billion INR 99.698%
Alpa Laboratories Limited 1.82 Billion INR 74.218%
Brooks Laboratories Limited 904.45 Million INR 47.944%
AstraZeneca Pharma India Limited 10.78 Billion INR 95.633%
Bajaj HealthCare Limited 7.65 Billion INR 93.846%
Bliss GVS Pharma Limited 12.13 Billion INR 96.121%
Dr. Reddy's Laboratories Limited 387.51 Billion INR 99.879%
Eris Lifesciences Limited 70.48 Billion INR 99.332%
FDC Limited 24.68 Billion INR 98.092%
Glenmark Pharmaceuticals Limited 143.58 Billion INR 99.672%
Gufic Biosciences Limited 10.92 Billion INR 95.691%
Ind-Swift Laboratories Limited 11.65 Billion INR 95.959%
Ipca Laboratories Limited 111.01 Billion INR 99.576%
Jagsonpal Pharmaceuticals Limited 2.17 Billion INR 78.311%
Krebs Biochemicals & Industries Limited 1.78 Billion INR 73.575%
Lasa Supergenerics Limited 1.5 Billion INR 68.792%
Laurus Labs Limited 83.87 Billion INR 99.439%
Lupin Limited 239.97 Billion INR 99.804%
Mankind Pharma Limited 119.63 Billion INR 99.606%
Medicamen Biotech Limited 2.94 Billion INR 84.014%
Medico Remedies Limited 961.95 Million INR 51.055%
Megasoft Limited 3.65 Billion INR 87.132%
NATCO Pharma Limited 69.06 Billion INR 99.318%
Piramal Pharma Limited 153.11 Billion INR 99.693%
RPG Life Sciences Limited 5.12 Billion INR 90.82%
Sigachi Industries Limited 6.94 Billion INR 93.217%
Sun Pharmaceutical Industries Limited 854.62 Billion INR 99.945%
Suven Pharmaceuticals Limited 22.54 Billion INR 97.911%
Syncom Formulations (India) Limited 4.04 Billion INR 88.365%
Unichem Laboratories Limited 31.69 Billion INR 98.514%
Wanbury Limited 3.43 Billion INR 86.293%
Windlas Biotech Limited 6.26 Billion INR 92.481%
ZIM Laboratories Limited 4.46 Billion INR 89.463%
Zydus Lifesciences Limited 292.8 Billion INR 99.839%
Sun Pharma Advanced Research Company Limited 5.15 Billion INR 90.858%
Divi's Laboratories Limited 154.7 Billion INR 99.696%
Hester Biosciences Limited 6.62 Billion INR 92.892%
Procter & Gamble Health Limited 7.94 Billion INR 94.073%
Amrutanjan Health Care Limited 3.66 Billion INR 87.166%
Bal Pharma Limited 3.2 Billion INR 85.305%
Strides Pharma Science Limited 58.39 Billion INR 99.194%
Venus Remedies Limited 6.26 Billion INR 92.489%
Aarti Pharmalabs Limited 25.82 Billion INR 98.177%
Nectar Lifesciences Limited 21.91 Billion INR 97.851%
Shilpa Medicare Limited 30.93 Billion INR 98.478%
Aarti Drugs Limited 24.32 Billion INR 98.064%
IOL Chemicals and Pharmaceuticals Limited 22.44 Billion INR 97.902%
Suven Life Sciences Limited 2.84 Billion INR 83.474%
Ind-Swift Limited 6.54 Billion INR 92.806%
Valiant Laboratories Limited 3.42 Billion INR 86.261%
J. B. Chemicals & Pharmaceuticals Limited 39.94 Billion INR 98.821%
Solara Active Pharma Sciences Limited 23.5 Billion INR 97.997%
Themis Medicare Limited 5.66 Billion INR 91.688%
Hikal Limited 24.87 Billion INR 98.107%
Torrent Pharmaceuticals Limited 150.61 Billion INR 99.687%
Sequent Scientific Limited 15.4 Billion INR 96.943%
Novartis India Limited 9.24 Billion INR 94.91%
Wockhardt Limited 76.49 Billion INR 99.384%
Jubilant Pharmova Limited 115.48 Billion INR 99.592%
Neuland Laboratories Limited 18.32 Billion INR 97.431%
Morepen Laboratories Limited 12.93 Billion INR 96.359%
Kilitch Drugs (India) Limited 2.4 Billion INR 80.387%
Mangalam Drugs & Organics Limited 3.33 Billion INR 85.879%